We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.09B
AUM Growth
-$461M
Cap. Flow
+$404M
Cap. Flow %
13.07%
Top 10 Hldgs %
27.53%
Holding
139
New
26
Increased
37
Reduced
15
Closed
17

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$72.8M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$58.7M
3
CRWD icon
CrowdStrike
CRWD
+$55.7M
4
DT icon
Dynatrace
DT
+$36.1M
5
DHI icon
D.R. Horton
DHI
+$33.2M

Top Sells

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$37.3M
2
TTD icon
Trade Desk
TTD
+$32.3M
3
PANW icon
Palo Alto Networks
PANW
+$30.4M
4
IAA
IAA, Inc. Common Stock
IAA
+$28.7M
5
PAYC icon
Paycom
PAYC
+$26.5M

Sector Composition

Rank Sector Weight
1 Healthcare 44.32%
2 Technology 23.01%
3 Industrials 9.93%
4 Consumer Discretionary 5.91%
5 Utilities 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PANW icon
51
Palo Alto Networks
PANW
$270B
$23.3M 0.75%
851,022
-870,978
-51% -$30.4M
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$23.1M 0.75%
301,000
– –
MGA icon
53
Magna International
MGA
$18.7B
$22.9M 0.74%
718,000
+131,000
+22% +$6.04M
SAGE
54
DELISTED
Sage Therapeutics
SAGE
$22.7M 0.73%
790,000
– –
VCYT icon
55
Veracyte
VCYT
$3.7B
$22.6M 0.73%
930,000
– –
DHI icon
56
D.R. Horton
DHI
$40B
$22.4M 0.73%
659,200
+638,100
+3,024% +$33.2M
NOVT icon
57
Novanta
NOVT
$5.08B
$22.4M 0.72%
280,000
– –
VRSK icon
58
Verisk Analytics
VRSK
$25.4B
$22M 0.71%
+158,000
New +$24.8M
STSA
59
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$20.6M 0.67%
983,382
+558,382
+131% +$12.7M
STML
60
DELISTED
Stemline Therapeutics, Inc.
STML
$20.1M 0.65%
4,160,608
– –
RCKT icon
61
Rocket Pharmaceuticals
RCKT
$340M
$19.7M 0.64%
1,415,000
– –
CTAS icon
62
Cintas
CTAS
$81.9B
$19.2M 0.62%
444,000
– –
AY
63
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$19.2M 0.62%
861,700
+67,100
+8% +$1.81M
HASI icon
64
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$17.2M 0.56%
844,600
+83,100
+11% +$2.63M
REGN icon
65
Regeneron Pharmaceuticals
REGN
$78.5B
$15.1M 0.49%
+30,900
New +$12.7M
XENE icon
66
Xenon Pharmaceuticals
XENE
$6.06B
$14.4M 0.47%
1,274,100
– –
CRNX icon
67
Crinetics Pharmaceuticals
CRNX
$8.84B
$13.9M 0.45%
947,000
– –
LW icon
68
Lamb Weston
LW
$7.22B
$13.8M 0.45%
242,400
+210,900
+670% +$17.3M
OKTA icon
69
Okta
OKTA
$24.7B
$13.2M 0.43%
108,000
+8,000
+8% +$1M
STRO icon
70
Sutro Biopharma
STRO
$401M
$13.1M 0.42%
128,598
+4,108
+3% +$432K
KALV
71
DELISTED
KalVista Pharmaceuticals
KALV
$12.9M 0.42%
1,680,000
– –
XLRN
72
DELISTED
Acceleron Pharma
XLRN
$12.8M 0.42%
+142,900
New +$11.1M
ISRG icon
73
Intuitive Surgical
ISRG
$127B
$12.4M 0.4%
75,000
– –
SWKS icon
74
Skyworks Solutions
SWKS
$9.37B
$12.1M 0.39%
+135,200
New +$14.4M
DDOG icon
75
Datadog
DDOG
$95.4B
$11.8M 0.38%
329,000
+29,000
+10% +$1.2M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Eventide Asset Management held 139 positions worth $3.09B, down 13% from $3.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q1 2020, opening 26 new positions and adding to 37 existing holdings. Its largest new stake was CrowdStrike: 3,948,000 shares worth $55M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Myovant Sciences Ltd., an estimated $37.3M trimmed.

  • Eventide Asset Management's largest Q1 2020 buy was CrowdStrike: 3,948,000 shares worth $55M.
  • Eventide Asset Management added most to Exact Sciences in Q1 2020, an estimated $72.8M increase.
  • Eventide Asset Management's biggest Q1 2020 reduction was Myovant Sciences Ltd., cutting an estimated $37.3M.
  • Eventide Asset Management fully exited IAA, Inc. Common Stock in Q1 2020, selling an estimated $28.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $3.09B portfolio in Q1 2020.
  • Eventide Asset Management opened 26 new positions and closed 17 in Q1 2020.
  • Eventide Asset Management's portfolio value fell 13% quarter-over-quarter to $3.09B.

Based on Eventide Asset Management's 13F filing for Q1 2020, filed 15 May 2020.